Anand Rohit, Nangia Sushma
Neonatology. 2025;122(1):4-10. doi: 10.1159/000539544. Epub 2024 Jul 17.
Providing adequate nutrition in the management of preterm infants has been challenging. The objective of this secondary analysis of data from the randomized trial comparing "less invasive surfactant therapy (LISA) with InSurE method of surfactant administration" is to demonstrate the feasibility of early total enteral feeding (ETEF) in hemodynamically stable preterm neonates on respiratory support and to examine the factors associated with failure of ETEF.
Secondary analysis of a randomized controlled trial comparing "LISA versus InSurE among preterm infants between 26 and 34 weeks of gestation" enrolled 150 infants with 117 being hemodynamically stable. ETEF without any parenteral supplementation was started on day 1 of life using the mother's own milk (MoM) or donor human milk (<32 weeks of GA) and MoM or preterm formula (33-34 weeks of GA). The data were analyzed to assess the proportion of babies developing feed intolerance and/or necrotizing enterocolitis (NEC) and factors associated with failure of ETEF. All Infants were assessed for the day of attainment of full enteral feeding defined as receiving and tolerating 150 mL/kg of enteral feeds per day.
Out of these 117 babies, 102 tolerated ETEF, and 15 had one or more episodes of FI requiring total parenteral nutrition, but none developed NEC till discharge or death. On the assessment of possible factors associated with ETEF failure, there were no differences in baseline characteristics but statistically significantly increased incidence of culture-positive sepsis as well as the requirement of antibiotic therapy for possible sepsis (early as well as late-onset sepsis) in babies with failure of ETEF. The babies who tolerated ETEF achieved full enteral feeding (150 mL/kg/day) significantly earlier (5.48 ± 1.1 days) compared to those with ETEF failure (7 ± 3.4 days) (p 0.001). The time to regain birth weight was earlier in the ETEF group without significant differences in growth parameters. There was also a reduction in the duration of hospital stay in babies who tolerated ETEF, but both these results were not statistically significant.
ETEF is feasible in preterm neonates with respiratory distress syndrome who are on respiratory support. It resulted in earlier attainment of full enteral feeds and decreased the incidence of sepsis with reduced antibiotic usage.
在早产儿的管理中提供充足的营养一直具有挑战性。这项对比较“微创表面活性剂治疗(LISA)与InSurE表面活性剂给药方法”的随机试验数据进行的二次分析的目的是证明在接受呼吸支持的血流动力学稳定的早产儿中进行早期全肠内喂养(ETEF)的可行性,并检查与ETEF失败相关的因素。
对一项比较“妊娠26至34周的早产儿中LISA与InSurE”的随机对照试验进行二次分析,纳入了150名婴儿,其中117名血流动力学稳定。出生后第1天开始使用母亲自己的母乳(MoM)或捐赠人乳(孕周<32周)以及MoM或早产儿配方奶(孕周33 - 34周)进行不添加任何肠外营养的ETEF。分析数据以评估出现喂养不耐受和/或坏死性小肠结肠炎(NEC)的婴儿比例以及与ETEF失败相关的因素。所有婴儿均评估达到全肠内喂养的天数,全肠内喂养定义为每天接受并耐受150 mL/kg的肠内喂养量。
在这117名婴儿中,102名耐受ETEF,15名有一次或多次喂养不耐受发作需要全肠外营养,但直至出院或死亡均无婴儿发生NEC。在评估与ETEF失败相关的可能因素时,基线特征无差异,但ETEF失败的婴儿中,培养阳性败血症的发生率以及因可能的败血症(早发型和晚发型败血症)而接受抗生素治疗的需求在统计学上显著增加。耐受ETEF的婴儿比ETEF失败的婴儿显著更早(5.48±1.1天)达到全肠内喂养(150 mL/kg/天)(p<0.001)。ETEF组恢复出生体重的时间更早,生长参数无显著差异。耐受ETEF的婴儿住院时间也有所缩短,但这两个结果均无统计学意义。
ETEF在接受呼吸支持的呼吸窘迫综合征早产儿中是可行的。它能使更早达到全肠内喂养,并降低败血症发生率,减少抗生素使用。